Oscar Health, Inc. (NYSE:OSCR – Get Free Report) CAO Victoria Baltrus sold 8,078 shares of the firm’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $146,050.24. Following the transaction, the chief accounting officer now directly owns 146,036 shares of the company’s stock, valued at $2,640,330.88. The trade was a 5.24 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.
Oscar Health Trading Down 3.3 %
Shares of OSCR stock opened at $16.40 on Friday. Oscar Health, Inc. has a fifty-two week low of $7.50 and a fifty-two week high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The stock has a 50 day simple moving average of $17.08 and a two-hundred day simple moving average of $17.93. The company has a market cap of $4.06 billion, a P/E ratio of -273.33 and a beta of 1.63.
Oscar Health (NYSE:OSCR – Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The company had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The business’s revenue was up 68.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.29) EPS. Research analysts forecast that Oscar Health, Inc. will post -0.01 earnings per share for the current year.
Hedge Funds Weigh In On Oscar Health
Analyst Ratings Changes
Several brokerages recently issued reports on OSCR. Bank of America lowered Oscar Health from a “neutral” rating to an “underperform” rating and lowered their target price for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. UBS Group started coverage on Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 price objective on the stock. Finally, Piper Sandler reiterated an “overweight” rating and issued a $28.00 target price on shares of Oscar Health in a report on Tuesday, September 10th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $22.93.
View Our Latest Stock Analysis on Oscar Health
Oscar Health Company Profile
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Further Reading
- Five stocks we like better than Oscar Health
- What is a Death Cross in Stocks?
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- Stock Market Upgrades: What Are They?
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- BlackRock Makes Waves With $12B Private Credit Acquisition
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.